Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer 
with Brain Metastasis

Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer 
with Brain Metastasis

Brain metastasis, a common complication of non-small cell lung cancer (NSCLC) with an incidence rate of 30%-50%, significantly affects the patients’ quality of life. The prognosis of patients of NSCLC with brain metastasis is extremely poor, the average median survival is only 1 m-2 m without treatm...

Full description

Bibliographic Details
Main Authors: Qi SONG, Shunchang JIAO, Fang LI
Format: Article
Language:zho
Published: Chinese Anti-Cancer Association; Chinese Antituberculosis Association 2016-08-01
Series:Chinese Journal of Lung Cancer
Subjects:
Lung neoplasms
Brain metastasis
Immunotherapy
Targeted therapy
Online Access:http://dx.doi.org/10.3779/j.issn.1009-3419.2016.08.08

Internet

http://dx.doi.org/10.3779/j.issn.1009-3419.2016.08.08

Similar Items